CytoSorbents, Inc. Enters Into Exclusive Distribution Agreement for CytoSorb® With L.IN.C. Medical Systems in the United Kingdom and Ireland

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MONMOUTH JUNCTION, N.J., May 6, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening illnesses, announced today that is has entered into an exclusive distribution agreement with L.IN.C Medical Systems LTD to distribute CytoSorb® in the United Kingdom and Ireland. The initial term of the agreement is three years, and is subject to annual minimum guaranteed orders of CytoSorb® to maintain exclusivity.

Help employers find you! Check out all the jobs and post your resume.

Back to news